
Sign up to save your podcasts
Or


Vidcast: https://youtu.be/7bsKp6g7-nE
Data from the earliest victims of CoVid, infected more than a year ago in Wuhan, now show durable protective immunity against this dread virus for 12 months or more. The longitudinal study of 1782 blood samples from 869 CoVid-surviving donors now appears online via the pre-publication server biorixiv.org.
Protective anti-CoVid antibody levels were present in 95% 1-2 months after infection but were still present in 89% at 6-7 months and in 81% at 12 months. Antibody strength does decline over time, but those with the highest initial titers had persistently protective antibodies.
Expect that vaccine-induced antibodies will last longer and be stronger.
https://www.biorxiv.org/content/10.1101/2021.04.05.437224v1.full.pdf+html
#CoVid #antibodies #vaccine #durability
By Howard G. Smith MD, AMVidcast: https://youtu.be/7bsKp6g7-nE
Data from the earliest victims of CoVid, infected more than a year ago in Wuhan, now show durable protective immunity against this dread virus for 12 months or more. The longitudinal study of 1782 blood samples from 869 CoVid-surviving donors now appears online via the pre-publication server biorixiv.org.
Protective anti-CoVid antibody levels were present in 95% 1-2 months after infection but were still present in 89% at 6-7 months and in 81% at 12 months. Antibody strength does decline over time, but those with the highest initial titers had persistently protective antibodies.
Expect that vaccine-induced antibodies will last longer and be stronger.
https://www.biorxiv.org/content/10.1101/2021.04.05.437224v1.full.pdf+html
#CoVid #antibodies #vaccine #durability